Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
52,094,206
-
Share change
-
+2,374,567
-
Total reported value
-
$5,741,576,836
-
Put/Call ratio
-
198%
-
Price per share
-
$110.34
-
Number of holders
-
376
-
Value change
-
+$270,141,092
-
Number of buys
-
178
-
Number of sells
-
208
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2020
As of 30 Jun 2020 Jazz Pharmaceuticals plc - SHS USD (JAZZ) had 376 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 52,094,206 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, LSV ASSET MANAGEMENT, AQR CAPITAL MANAGEMENT LLC, JPMORGAN CHASE & CO, FMR LLC, STATE STREET CORP, Nuveen Asset Management, LLC, and CITADEL ADVISORS LLC.
This table shows 377 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.